HomeCompareMAIN vs MRK

MAIN vs MRK: Dividend Comparison 2026

MAIN yields 8.41% · MRK yields 3.25% · See full DRIP projection below

vsEnter any two US tickers
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $26.4K in total portfolio value
10 years
MAIN
Main Street Capital Corporation
8.41%
Share price
$52.80
Annual div
$4.44
5Y div CAGR
5.1%
Payout ratio
82%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.2K
Annual income
$2,355.47
Full MAIN calculator →
MRK
Merck & Co. Inc.
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — MAIN vs MRK

Annual dividend income

MetricMAINMRK
Forward yield8.41%3.25%
Annual dividend / share$4.44$3.08
Payout ratio82%42%
1-year div growth3.7%5.5%
5-year div CAGR5.1%8.2%
Portfolio after 10y$57.2K$30.7K
Annual income after 10y$2,355.47$950.29
Total dividends collected$15.5K$6.1K
Payment frequencymonthlyquarterly
SectorBDCHealthcare

Year-by-year: MAIN vs MRK ($10,000, DRIP)

YearMAIN PortfolioMAIN Income/yrMRK PortfolioMRK Income/yrGap
1$12,124$883.80$11,192$351.54+$932.00MAIN
2$14,629$1,001.91$12,524$392.70+$2.1KMAIN
3$17,573$1,130.42$14,015$438.65+$3.6KMAIN
4$21,022$1,269.75$15,682$489.96+$5.3KMAIN
5$25,049$1,420.29$17,547$547.23+$7.5KMAIN
6$29,738$1,582.45$19,632$611.16+$10.1KMAIN
7$35,182$1,756.64$21,963$682.53+$13.2KMAIN
8$41,488$1,943.25$24,571$762.18+$16.9KMAIN
9$48,775$2,142.72$27,486$851.08+$21.3KMAIN
10$57,179$2,355.47$30,745$950.29+$26.4KMAIN

MAIN vs MRK: Complete Analysis 2026

MAINBDC

Main Street Capital is a Business Development Company providing debt and equity capital to lower middle market companies. It pays regular monthly dividends plus semi-annual special dividends. One of the few BDCs consistently trading at a premium to NAV, with an exceptional track record since its 2007 IPO. Often called the gold standard of BDCs.

Full MAIN Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

Frequently Asked Questions

Is MAIN or MRK better for dividend income in 2026?
MAIN currently offers a 8.41% yield (4.44/share/year) while MRK offers 3.25% (3.08/share/year). MAIN provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MAIN vs MRK earn per year?
With $10,000 invested today: MAIN pays approximately $841/year. MRK pays approximately $325/year. With DRIP reinvestment over 10 years, these grow to $2,355/year (MAIN) and $950/year (MRK).
Does MAIN or MRK pay monthly dividends?
MAIN pays monthly dividends. MRK pays quarterly dividends. MAIN pays monthly, which is preferred by investors who need regular cash flow.
📬

Get this MAIN vs MRK comparison by email

Save your analysis + get weekly dividend insights. Free forever.

More comparisons

MAIN vs ARCCMAIN vs HTGCMAIN vs GBDCMAIN vs ORCCMAIN vs CSWCMAIN vs JNJMAIN vs ABBVMAIN vs PFEMRK vs JNJMRK vs ABBVMRK vs PFEMRK vs BMY

⚠️ Educational purposes only. Not financial advice. All projections use historical data; actual results will vary.